Sameer Muchhala

Efficacy of Fixed-dose Combination of Dapagliflozin and Sitagliptin in Type 2 Diabetes Mellitus Using Continuous Glucose Monitoring: A Real-world Study in India

Supratik Bhattacharyya, Sameer Muchhala & Kunal Jhaveri · Journal of Advances in Medical and Pharmaceutical Sciences · 2023

Background: Type 2 diabetes mellitus (T2DM) is a progressive disease with multifactorial aetiology. Metformin monotherapy is commonly used as the initial treatment, but is often inadequate in achieving optimal glycaemic control, necessitating the need of second and third-line the...

Open access Research Article 10.9734/jamps/2023/v25i6621

Real World Evidence of Bempedoic Acid on Efficacy and Safety in Patients with Uncontrolled LDL-c and at High Risk of CVD

S. Manoj, Jay Shah, Dilip Kumar, Akshaya Pradhan, Amit B. Kinare, Ashwani Kumar Sharma, M. S. Aditya, Ram Anil Raj, Akhter Amin Raina, Ashish Patel, Biswajit Das, Dipak Suresh Bathe, Sameer Muchhala & Kunal Jhaveri · Cardiology and Angiology: An International Journal · 2023

Background and Objective: Cardiovascular disease (CVD) is a significant cause of morbidity and mortality worldwide, with high-risk patients requiring effective management to reduce their risk of cardiovascular events. Bempedoic acid is a novel therapeutic agent recently approved...

Open access Research Article 10.9734/ca/2023/v12i4350